Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05432245 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MINIject Implantation Combined With Cataract Surgery in Patients With POAG and Cataract

Study acronym: STAR-VI
StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 28, 2025 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jul 2023 to Jul 2025v4
  2. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Start date changed from estimate of Sep 2022 to Jan 18, 2023
    • Study sites: 1 to 4
    • Study completion date: Jan 2025 to Jul 2025
    v3
  3. Start date: Aug 2022 to Sep 2022
    • Site contact updated
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study will assess safety and performance of MINIject implant in patients with open-angle glaucoma uncontrolled by topical hypotensive medications in conjunction with cataract surgery.
Trial Details
NCT Number NCT05432245
Lead Sponsor iSTAR Medical
Conditions
(from sponsor)		 Primary Open-angle Glaucoma, Cataract
Related terms Cataract, Glaucoma, Open-Angle
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov